Global Temozolomide Sales Market Report 2016

October 2016 | 118 pages | ID: GF560350092EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Temozolomide

Revenue, means the sales value of Temozolomide

This report studies sales (consumption) of Temozolomide in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Merck & Co., Inc.
• Tianjin Tasly Pharmaceutical Co.,Ltd
• Miracalus
• Sun
• Macleods
• BMW
• Cipla
• Ind- Swift
• Panacea
• Fulford
• Celon
• Natco
• Lunarsun
• LUMMY
• Jianyuan

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Temozolomide in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Product in Semi Regulated Markets
• Product in Regulated Markets
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Temozolomide in each application, can be divided into

• Nitrosourea- and procarbazine-refractory anaplastic astrocytoma
• Newly diagnosed glioblastoma multiforme
• Application 3

Contents

Global Temozolomide Sales Market Report 2016

1 TEMOZOLOMIDE OVERVIEW

1.1 Product Overview and Scope of Temozolomide
1.2 Classification of Temozolomide
  1.2.1 Product in Semi Regulated Markets
  1.2.2 Product in Regulated Markets
  1.2.3 Type III
1.3 Application of Temozolomide
  1.3.1 Nitrosourea- and procarbazine-refractory anaplastic astrocytoma
  1.3.2 Newly diagnosed glioblastoma multiforme
  1.3.3 Application
1.4 Temozolomide Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Temozolomide (2011-2021)
  1.5.1 Global Temozolomide Sales and Growth Rate (2011-2021)
  1.5.2 Global Temozolomide Revenue and Growth Rate (2011-2021)

2 GLOBAL TEMOZOLOMIDE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Temozolomide Market Competition by Manufacturers
  2.1.1 Global Temozolomide Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Temozolomide Revenue and Share by Manufacturers (2011-2016)
2.2 Global Temozolomide (Volume and Value) by Type
  2.2.1 Global Temozolomide Sales and Market Share by Type (2011-2016)
  2.2.2 Global Temozolomide Revenue and Market Share by Type (2011-2016)
2.3 Global Temozolomide (Volume and Value) by Regions
  2.3.1 Global Temozolomide Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Temozolomide Revenue and Market Share by Regions (2011-2016)
2.4 Global Temozolomide (Volume) by Application

3 UNITED STATES TEMOZOLOMIDE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Temozolomide Sales and Value (2011-2016)
  3.1.1 United States Temozolomide Sales and Growth Rate (2011-2016)
  3.1.2 United States Temozolomide Revenue and Growth Rate (2011-2016)
  3.1.3 United States Temozolomide Sales Price Trend (2011-2016)
3.2 United States Temozolomide Sales and Market Share by Manufacturers
3.3 United States Temozolomide Sales and Market Share by Type
3.4 United States Temozolomide Sales and Market Share by Application

4 CHINA TEMOZOLOMIDE (VOLUME, VALUE AND SALES PRICE)

4.1 China Temozolomide Sales and Value (2011-2016)
  4.1.1 China Temozolomide Sales and Growth Rate (2011-2016)
  4.1.2 China Temozolomide Revenue and Growth Rate (2011-2016)
  4.1.3 China Temozolomide Sales Price Trend (2011-2016)
4.2 China Temozolomide Sales and Market Share by Manufacturers
4.3 China Temozolomide Sales and Market Share by Type
4.4 China Temozolomide Sales and Market Share by Application

5 EUROPE TEMOZOLOMIDE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Temozolomide Sales and Value (2011-2016)
  5.1.1 Europe Temozolomide Sales and Growth Rate (2011-2016)
  5.1.2 Europe Temozolomide Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Temozolomide Sales Price Trend (2011-2016)
5.2 Europe Temozolomide Sales and Market Share by Manufacturers
5.3 Europe Temozolomide Sales and Market Share by Type
5.4 Europe Temozolomide Sales and Market Share by Application

6 JAPAN TEMOZOLOMIDE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Temozolomide Sales and Value (2011-2016)
  6.1.1 Japan Temozolomide Sales and Growth Rate (2011-2016)
  6.1.2 Japan Temozolomide Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Temozolomide Sales Price Trend (2011-2016)
6.2 Japan Temozolomide Sales and Market Share by Manufacturers
6.3 Japan Temozolomide Sales and Market Share by Type
6.4 Japan Temozolomide Sales and Market Share by Application

7 GLOBAL TEMOZOLOMIDE MANUFACTURERS ANALYSIS

7.1 Merck & Co., Inc.
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Temozolomide Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Merck & Co., Inc. Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Tianjin Tasly Pharmaceutical Co.,Ltd
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 118 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Tianjin Tasly Pharmaceutical Co.,Ltd Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Miracalus
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 134 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Miracalus Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Sun
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Oct Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Sun Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Macleods
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Macleods Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 BMW
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 BMW Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Cipla
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Cipla Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Ind- Swift
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Ind- Swift Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Panacea
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Panacea Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Fulford
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Fulford Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Celon
7.12 Natco
7.13 Lunarsun
7.14 LUMMY
7.15 Jianyuan

8 TEMOZOLOMIDE MAUFACTURING COST ANALYSIS

8.1 Temozolomide Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Temozolomide

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Temozolomide Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Temozolomide Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL TEMOZOLOMIDE MARKET FORECAST (2016-2021)

12.1 Global Temozolomide Sales, Revenue Forecast (2016-2021)
12.2 Global Temozolomide Sales Forecast by Regions (2016-2021)
12.3 Global Temozolomide Sales Forecast by Type (2016-2021)
12.4 Global Temozolomide Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Temozolomide
Table Classification of Temozolomide
Figure Global Sales Market Share of Temozolomide by Type in 2015
Figure Product in Semi Regulated Markets Picture
Figure Product in Regulated Markets Picture
Table Applications of Temozolomide
Figure Global Sales Market Share of Temozolomide by Application in 2015
Figure Nitrosourea- and procarbazine-refractory anaplastic astrocytoma Examples
Figure Newly diagnosed glioblastoma multiforme Examples
Figure United States Temozolomide Revenue and Growth Rate (2011-2021)
Figure China Temozolomide Revenue and Growth Rate (2011-2021)
Figure Europe Temozolomide Revenue and Growth Rate (2011-2021)
Figure Japan Temozolomide Revenue and Growth Rate (2011-2021)
Figure Global Temozolomide Sales and Growth Rate (2011-2021)
Figure Global Temozolomide Revenue and Growth Rate (2011-2021)
Table Global Temozolomide Sales of Key Manufacturers (2011-2016)
Table Global Temozolomide Sales Share by Manufacturers (2011-2016)
Figure 2015 Temozolomide Sales Share by Manufacturers
Figure 2016 Temozolomide Sales Share by Manufacturers
Table Global Temozolomide Revenue by Manufacturers (2011-2016)
Table Global Temozolomide Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Temozolomide Revenue Share by Manufacturers
Table 2016 Global Temozolomide Revenue Share by Manufacturers
Table Global Temozolomide Sales and Market Share by Type (2011-2016)
Table Global Temozolomide Sales Share by Type (2011-2016)
Figure Sales Market Share of Temozolomide by Type (2011-2016)
Figure Global Temozolomide Sales Growth Rate by Type (2011-2016)
Table Global Temozolomide Revenue and Market Share by Type (2011-2016)
Table Global Temozolomide Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Temozolomide by Type (2011-2016)
Figure Global Temozolomide Revenue Growth Rate by Type (2011-2016)
Table Global Temozolomide Sales and Market Share by Regions (2011-2016)
Table Global Temozolomide Sales Share by Regions (2011-2016)
Figure Sales Market Share of Temozolomide by Regions (2011-2016)
Figure Global Temozolomide Sales Growth Rate by Regions (2011-2016)
Table Global Temozolomide Revenue and Market Share by Regions (2011-2016)
Table Global Temozolomide Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Temozolomide by Regions (2011-2016)
Figure Global Temozolomide Revenue Growth Rate by Regions (2011-2016)
Table Global Temozolomide Sales and Market Share by Application (2011-2016)
Table Global Temozolomide Sales Share by Application (2011-2016)
Figure Sales Market Share of Temozolomide by Application (2011-2016)
Figure Global Temozolomide Sales Growth Rate by Application (2011-2016)
Figure United States Temozolomide Sales and Growth Rate (2011-2016)
Figure United States Temozolomide Revenue and Growth Rate (2011-2016)
Figure United States Temozolomide Sales Price Trend (2011-2016)
Table United States Temozolomide Sales by Manufacturers (2011-2016)
Table United States Temozolomide Market Share by Manufacturers (2011-2016)
Table United States Temozolomide Sales by Type (2011-2016)
Table United States Temozolomide Market Share by Type (2011-2016)
Table United States Temozolomide Sales by Application (2011-2016)
Table United States Temozolomide Market Share by Application (2011-2016)
Figure China Temozolomide Sales and Growth Rate (2011-2016)
Figure China Temozolomide Revenue and Growth Rate (2011-2016)
Figure China Temozolomide Sales Price Trend (2011-2016)
Table China Temozolomide Sales by Manufacturers (2011-2016)
Table China Temozolomide Market Share by Manufacturers (2011-2016)
Table China Temozolomide Sales by Type (2011-2016)
Table China Temozolomide Market Share by Type (2011-2016)
Table China Temozolomide Sales by Application (2011-2016)
Table China Temozolomide Market Share by Application (2011-2016)
Figure Europe Temozolomide Sales and Growth Rate (2011-2016)
Figure Europe Temozolomide Revenue and Growth Rate (2011-2016)
Figure Europe Temozolomide Sales Price Trend (2011-2016)
Table Europe Temozolomide Sales by Manufacturers (2011-2016)
Table Europe Temozolomide Market Share by Manufacturers (2011-2016)
Table Europe Temozolomide Sales by Type (2011-2016)
Table Europe Temozolomide Market Share by Type (2011-2016)
Table Europe Temozolomide Sales by Application (2011-2016)
Table Europe Temozolomide Market Share by Application (2011-2016)
Figure Japan Temozolomide Sales and Growth Rate (2011-2016)
Figure Japan Temozolomide Revenue and Growth Rate (2011-2016)
Figure Japan Temozolomide Sales Price Trend (2011-2016)
Table Japan Temozolomide Sales by Manufacturers (2011-2016)
Table Japan Temozolomide Market Share by Manufacturers (2011-2016)
Table Japan Temozolomide Sales by Type (2011-2016)
Table Japan Temozolomide Market Share by Type (2011-2016)
Table Japan Temozolomide Sales by Application (2011-2016)
Table Japan Temozolomide Market Share by Application (2011-2016)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. Temozolomide Global Market Share (2011-2016)
Table Tianjin Tasly Pharmaceutical Co.,Ltd Basic Information List
Table Tianjin Tasly Pharmaceutical Co.,Ltd Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Tianjin Tasly Pharmaceutical Co.,Ltd Temozolomide Global Market Share (2011-2016)
Table Miracalus Basic Information List
Table Miracalus Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Miracalus Temozolomide Global Market Share (2011-2016)
Table Sun Basic Information List
Table Sun Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sun Temozolomide Global Market Share (2011-2016)
Table Macleods Basic Information List
Table Macleods Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Macleods Temozolomide Global Market Share (2011-2016)
Table BMW Basic Information List
Table BMW Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BMW Temozolomide Global Market Share (2011-2016)
Table Cipla Basic Information List
Table Cipla Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cipla Temozolomide Global Market Share (2011-2016)
Table Ind- Swift Basic Information List
Table Ind- Swift Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ind- Swift Temozolomide Global Market Share (2011-2016)
Table Panacea Basic Information List
Table Panacea Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Panacea Temozolomide Global Market Share (2011-2016)
Table Fulford Basic Information List
Table Fulford Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Fulford Temozolomide Global Market Share (2011-2016)
Table Celon Basic Information List
Table Celon Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celon Temozolomide Global Market Share (2011-2016)
Table Natco Basic Information List
Table Natco Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Natco Temozolomide Global Market Share (2011-2016)
Table Lunarsun Basic Information List
Table Lunarsun Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lunarsun Temozolomide Global Market Share (2011-2016)
Table LUMMY Basic Information List
Table LUMMY Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure LUMMY Temozolomide Global Market Share (2011-2016)
Table Jianyuan Basic Information List
Table Jianyuan Temozolomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Jianyuan Temozolomide Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Temozolomide
Figure Manufacturing Process Analysis of Temozolomide
Figure Temozolomide Industrial Chain Analysis
Table Raw Materials Sources of Temozolomide Major Manufacturers in 2015
Table Major Buyers of Temozolomide
Table Distributors/Traders List
Figure Global Temozolomide Sales and Growth Rate Forecast (2016-2021)
Figure Global Temozolomide Revenue and Growth Rate Forecast (2016-2021)
Table Global Temozolomide Sales Forecast by Regions (2016-2021)
Table Global Temozolomide Sales Forecast by Type (2016-2021)
Table Global Temozolomide Sales Forecast by Application (2016-2021)